Mumbai (Maharashtra) [India], March 16 (ANI): At the age of just 20, Rajasthan Royals' youngster Riyan Parag will be taking part in his fourth season of the Indian Premier League (IPL) when his team starts their campaign in Pune in a fortnight's time.
New Delhi [India], March 16 (ANI): As India's COVID-19 vaccination drive expanded to children in the age group 12-14 years, and those above 60 also became eligible for precaution dose, Prime Minister Narendra Modi on Wednesday urged people in these age groups to get vaccinated.
Kolkata (West Bengal) [India], March 14 (ANI): Trinamool Congress (TMC) candidate for the Ballygunge Assembly seat bypoll, Babul Supriyo, started his campaign on Monday. The election is scheduled for April 12.
Hyderabad (Telangana), March 14 (ANI): Telangana government has announced the commencement of half-day schools from 15th March till the last working day of the academic year 2021-22 as the state experiences rising temperature.
California [USA], March 13 (ANI): Defending champion Paula Badosa started her campaign with a victory over Tereza Martincova, to move into the third round at Indian Wells on Saturday.
New Delhi [India], March 12 (ANI): One of the highlights of the 2021 season for the Rajasthan Royals was the top-order exploits from promising youngster Yashasvi Jaiswal, who held the responsibility of providing blistering starts to the team at a strike rate of 148.21 across 10 matches.
Mumbai (Maharashtra) [India], March 11 (ANI): Katrina Kaif has been making the headlines ever since her wedding with actor Vicky Kaushal. The actor, who was recently seen in the teaser of her upcoming film, 'Tiger 3', with Salman Khan, kickstarted the shooting of the Sriram Raghavan director
New Delhi [India], March 11 (ANI): Bharat Biotech's intranasal booster vaccine can be a game-changer if it provides mucosal immunity against COVID-19, said Dr Sanjay Rai, Professor for Community Medicine at AIIMS as the clinical trials for the vaccine commenced on Friday.
Washington [US], March 9 (ANI): Pharmaceutical company Pfizer on Tuesday (local time) stated that it has started the Phase 2/3 clinical study to evaluate the safety and efficacy of its COVID-19 oral treatment in the pediatric population at risk of progression to severe disease.